How many drugs from drugs.com's top 100 drugs have you taken?
0
1-5
6-10
11-15
16-20
21-25
26-49
50-100

seen from Kazakhstan

seen from Sweden

seen from Australia

seen from Australia

seen from United Kingdom

seen from United Kingdom
seen from United States
seen from Hong Kong SAR China
seen from Australia

seen from United Kingdom
seen from United States
seen from United States

seen from South Africa
seen from Malaysia
seen from China
seen from United Kingdom
seen from Netherlands
seen from United States
seen from Iraq
seen from Malaysia
How many drugs from drugs.com's top 100 drugs have you taken?
0
1-5
6-10
11-15
16-20
21-25
26-49
50-100
Sometimes, I talk to straight people, and I realize just how little they think about HIV/AIDS. Like, when I talk to other mlms, "did you see the article about the latest vaccine trial" or "my doctor just switched me from Truvada to Descovy" are casual conversation topics. And then I talk to cishets and they still think it's 1989 and being HIV-positive is an automatic death sentence.
Okay, so I finished it.
I’ll just say one thing. “Don’t ever get rid of that crop top” I actually SCREAMED at this point. It was so unexpected!
It was a beautifull chapter Roc. It did not disappoint me at all (I’m the James lover anon), i loved the way you conveyed james paranoia and what he thinks when he loses some control over himself in a way. I also loved the way you described everything unspoken, THE FINAL TENSION I felt it all!
Plus: I like the way you “advertise” safe sex
Hi James lover anon 💕
Thank you so much, I’m glad you enjoyed it! This and ch13 (the one with James’ memories) were the hardest two to write. Focusing on James’ internal turmoil whilst including his feelings about Regulus and also the progress he’s making is very hard on me. It’s draining mentally and emotionally and it never feels quite good enough. So makes me super happy when it gets appreciated, thank you so much dear 😊
And yes, safe sex! Although Regulus does not need to take the PrEP, I don’t think many people have heard about it and I wanted to include it in the story. It would be more relevant for the Marauders, their risk as injecting drug users is much higher than Regulus’, but I wanted to show it from the sexual point of view.
I posted the chapter extremely sleep deprived so my end notes explanation was a bit poor. I updated it now, but here it is too, for people who may be interested:
Citing a lack of evidence, the agency will require Gilead to conduct additional trials in individuals ‘who have receptive vaginal sex.’
The Food and Drug Administration on Thursday approved a new drug, Descovy, for prevention of infection with H.I.V., only the second drug approved for this purpose.
The first, Truvada, has become a mainstay of government efforts to turn back the H.I.V. epidemic. But the F.D.A.’s approval of Descovy explicitly excludes “individuals who have receptive vaginal sex,” which may include cisgender women and many transgender men, and does not outline a plan for making the drug available to them.
The drug’s maker, Gilead Sciences, tested it only “in men and transgender women,” the F.D.A. noted. Some activists and scientists said the approval sets a dangerous precedent by allowing companies to dodge the expensive trials needed to test medicines in cisgender women and other groups at risk of H.I.V. infection.
Such an exclusion “should be unacceptable in these days and times,” said Dr. Rochelle Walensky, chief of infectious diseases at Massachusetts General Hospital.
It’s important to test the drug specifically in cisgender women and some transgender men, she added, because Descovy may work differently in the vagina than in rectal tissues.
read more
The U.S. Health Department launched Ready, Set, PrEP to provide the HIV prevention med at no cost.
Thanks to a national program called Ready, Set, PrEP, people who don’t have insurance for prescription drugs can now get free pre-exposure prophylaxis (PrEP), the daily pill to prevent contracting HIV. However, the cost of related clinic visits and lab work may vary depending on the person’s income.
CVS Health, Walgreens and Rite Aid are participating in the federal program. This means that by March 30, 2020, PrEP medication can be picked up at their more than 21,000 pharmacies.
The Department of Health and Human Services (HHS) launched the program December 3, according to an HHS press release. The program is part of the federal initiative “Ending the HIV Epidemic: A Plan for America” that aims to lower HIV rates nationwide by 75% in five years and by 90% in 10 years. One way to reach that goal is by increasing access to PrEP.
FDA backs Gilead's HIV prevention drug Descovy for use as PrEP
An FDA advisory panel on Wednesday voted in favor of Gilead Sciences Inc's combination drug to reduce the risk of sexually acquired HIV infection in men and transgender women who have sex with men.
Read More.
For people at high risk of HIV, taking a daily dose of a prevention drug is essential. But many can't afford it. A new federal program makes the drugs available for free.
Called Ready, Set, PrEP, the federal program will provide patients at risk of contracting HIV one of the two pre-exposure prophylaxis (PrEP) drugs. Those medications can reduce the chances of getting HIV through sex by more than 90%.
The medications, Truvada and Descovy, are made possible in part by a donation from the drugs' manufacturer, Gilead Sciences. That would cover the drugs for up to 200,000 uninsured individuals each year for the next 11 years. The federal government, however, is paying the drugmaker for several months to distribute the medications.
If you are interested in signing up for the program, here's what you need to know
This finding calls into question research that has projected that frequent testing among men on PrEP could drive down STI rates.
Health care providers overseeing pre-exposure prophylaxis (PrEP) use among men who have sex with men (MSM) are far from meeting guidelines for routine sexually transmitted infection (STI) testing in this population, aidsmap reports.
Testing rates are notably poor in the South, where STIs are the most prevalent.
These findings from a new study published in Clinical Infectious Diseases calls into question previous research that projected that the routine STI testing that is supposed to go hand in hand with an ongoing PrEP prescription would lead to a decline in STIs among MSM taking Truvada (tenofovir disoproxil fumarate/emtricitabine) or Descovy (tenofovir alafenamide/emtricitabine) for prevention of HIV.